Parthasarathl Rajagopalan

Title: Parthasarathl Rajagopalan: Innovator in Pharmaceutical Compounds

Introduction

Parthasarathl Rajagopalan is a notable inventor based in Chennai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds aimed at treating various central nervous system disorders. With a total of 2 patents to his name, his work is recognized for its potential impact on healthcare.

Latest Patents

Rajagopalan's latest patents focus on "Substituted heterocycle fused gamma-carbolines." These inventions are directed towards novel compounds represented by specific structural formulas, which include pharmaceutically acceptable salt forms. The compounds are designed to act as serotonin agonists and antagonists, proving useful in the control or prevention of disorders such as obesity, anxiety, depression, psychosis, schizophrenia, sleep disorders, sexual disorders, migraines, and gastrointestinal dysfunctions.

Career Highlights

Currently, Rajagopalan is associated with Bristol-Myers Squibb Pharma Company, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for complex health issues.

Collaborations

Throughout his career, Rajagopalan has collaborated with esteemed colleagues, including Albert Jean Robichaud and Taekyu Lee. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Parthasarathl Rajagopalan stands out as a significant figure in the pharmaceutical industry, with his innovative work paving the way for new treatments for various disorders. His contributions are vital to the ongoing efforts in improving mental health and overall well-being.